Regulation Of Pharmaceutical Competition In Generic Drug Market

Abstract

The application of competition and consumer protection rules in both Algeria and France is influenced by the unique characteristics of the pharmaceutical market. This is what this paper concluded by highlighting how "pharmaceutical competition" is regulated for generic drugs, especially in the French market, with alluding to Algerian market. This is in light of the crucial role played by the competition authorities of both countries to fight against restrictive and anti-competitive practices and commercial denigration of the reputation of generic medicines with a view to preventing them from entering the market. This is evident through the analysis of the competition authority's opinions decisions and some jurisprudence in this context.